We also evaluated the prognostic value of Ki67+ Treg/T in different treatment arms, and the results from both trials consistently showed that lower Ki67+ Treg/T was associated with longer EFS in NPC patients who received aPD1-CRT but not in those who received CRT alone (Supplementary Fig. 12). Here, MKI67 is linked to nasopharyngeal carcinoma.